NCT00607789View on ClinicalTrials.gov

Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Binge EatingDepression
Interventions
DRUG

Duloxetine

30 mg/day - 120 mg/day

DRUG

Placebo

identical to study drug

Trial Locations (1)

45219

University of Cincinnati and Lindner Center of HOPE, Cincinnati

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Cincinnati

OTHER

NCT00607789 - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression | Biotech Hunter | Biotech Hunter